Skip to search formSkip to main contentSkip to account menu

PLCG2 gene

Known as: PHOSPHOLIPASE C, GAMMA-2, Phospholipase C, Gamma 2 (Phosphatidylinositol-Specific) Gene, PLCG2 
This gene is involved in the generation of second messengers in the transmembrane signaling of ligand-activated growth factor receptors.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Purpose Therapeutic targeting of Bruton tyrosine kinase (BTK) with ibrutinib in chronic lymphocytic leukemia has led to a… 
2017
2017
We recently demonstrated that obinutuzumab (GA101), a novel glycoengineered type II CD20 Ab compared to rituximab (RTX) mediates… 
2016
2016
The Bruton9s Tyrosine Kinase (BTK) inhibitor ibrutinib is very effective in chronic lymphocytic leukemia (CLL). Resistance in CLL… 
2015
2015
Osteosarcoma (OS) is the most common type of primary bone malignancy and has a poor prognosis. To investigate the mechanisms of… 
2001
2001
Abstract. Our recent studies using targeted gene disruption have shown that defects in phospholipase Cγ2 (PLCγ2) result in a B… 
1995
1995
The phospholipase C gamma-2 (Plcg2) gene encodes an enzyme that plays a crucial role in intracellular signal transduction… 
1994
1994
We have mapped the PLCG2 gene, which encodes the enzyme phosphatidyl inositol-specific phospholipase C-gamma 2. This is one of…